Literature DB >> 14708121

Escherichia coli--a model system that benefits from and contributes to the evolution of proteomics.

Pat S Lee1, Kelvin H Lee.   

Abstract

The large body of knowledge about Escherichia coli makes it a useful model organism for the expression of heterologous proteins. Proteomic studies have helped to elucidate the complex cellular responses of E. coli and facilitated its use in a variety of biotechnology applications. Knowledge of basic cellular processes provides the means for better control of heterologous protein expression. Beyond such important applications, E. coli is an ideal organism for testing new analytical technologies because of the extensive knowledge base available about the organism. For example, improved technology for characterization of unknown proteins using mass spectrometry has made two-dimensional electrophoresis (2DE) studies more useful and more rewarding, and much of the initial testing of novel protocols is based on well-studied samples derived from E. coli. These techniques have facilitated the construction of more accurate 2DE maps. In this review, we present work that led to the 2DE databases, including a new map based on tandem time-of-flight (TOF) mass spectrometry (MS); describe cellular responses relevant to biotechnology applications; and discuss some emerging proteomic techniques. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708121     DOI: 10.1002/bit.10848

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  14 in total

1.  Parallel changes in global protein profiles during long-term experimental evolution in Escherichia coli.

Authors:  Ludovic Pelosi; Lauriane Kühn; Dorian Guetta; Jérôme Garin; Johannes Geiselmann; Richard E Lenski; Dominique Schneider
Journal:  Genetics       Date:  2006-05-15       Impact factor: 4.562

2.  Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical.

Authors:  Ilana S Aldor; Denise C Krawitz; William Forrest; Christina Chen; Julie C Nishihara; John C Joly; Kathleen M Champion
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

Review 3.  The Escherichia coli proteome: past, present, and future prospects.

Authors:  Mee-Jung Han; Sang Yup Lee
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

4.  Protein solubility and differential proteomic profiling of recombinant Escherichia coli overexpressing double-tagged fusion proteins.

Authors:  Chung-Hsien Cheng; Wen-Chien Lee
Journal:  Microb Cell Fact       Date:  2010-08-28       Impact factor: 5.328

5.  Genomic differences between Campylobacter jejuni isolates identify surface membrane and flagellar function gene products potentially important for colonizing the chicken intestine.

Authors:  Kelli L Hiett; Alain Stintzi; Tracy M Andacht; Robin L Kuntz; Bruce S Seal
Journal:  Funct Integr Genomics       Date:  2008-07-01       Impact factor: 3.410

Review 6.  Insights into the biology of Escherichia coli through structural proteomics.

Authors:  Allan Matte; Zongchao Jia; S Sunita; J Sivaraman; Miroslaw Cygler
Journal:  J Struct Funct Genomics       Date:  2007-08-01

7.  The bag or the spindle: the cell factory at the time of systems' biology.

Authors:  Antoine Danchin
Journal:  Microb Cell Fact       Date:  2004-11-10       Impact factor: 5.328

8.  Viability of Escherichia coli ATCC 8739 in Nutrient Broth, Luria-Bertani Broth and Brain Heart Infusion over 11 Weeks.

Authors:  Samuel Xin Zher Low; Zhen Qin Aw; Bryan Zong Lin Loo; Kun Cheng Lee; Jack Si Hao Oon; Chin How Lee; Maurice Han Tong Ling
Journal:  Electron Physician       Date:  2013-02-01

9.  Impact of pyrrolidine-bispyrrole DNA minor groove binding agents and chirality on global proteomic profile in Escherichia Coli.

Authors:  Ya-Ting Yang; Chun-Yu Lin; Jingyueh Jeng; Chi-Wi Ong
Journal:  Proteome Sci       Date:  2013-05-23       Impact factor: 2.480

10.  A semi-quantitative GeLC-MS analysis of temporal proteome expression in the emerging nosocomial pathogen Ochrobactrum anthropi.

Authors:  Robert Leslie James Graham; Mohit K Sharma; Nigel G Ternan; D Brent Weatherly; Rick L Tarleton; Geoff McMullan
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.